atorvastatin has been researched along with Brain Neoplasms in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Aldanan, S; Alghareeb, WA; Alhussain, H; AlNajjar, FH; Alsaeed, E; Alsharm, AA; Altwairgi, AK; Balbaid, AAO; Orz, Y | 1 |
Gao, X; Gu, Y; Li, J; Qin, J; Sun, C; Xiao, L; Yang, H; Yang, R; Yang, Y; Ye, J; Yuan, Y; Zhang, F; Zhang, J; Zhang, L; Zhao, Y | 1 |
Li, J; Long, C; Peng, P; Wei, W | 1 |
Lei, C; Shuyun, H; Xiangrong, C; Yiquan, K; Yongjun, Y; Zhilin, Y | 1 |
Dal-Cim, T; Lopes, FG; Ludka, FK; Nedel, CB; Oliveira, KA; Tasca, CI | 1 |
Ai, A; Ai, J; Ardakan, MMM; Bayat, N; Ebrahimi-Barough, S; Norouzi-Javidan, A; Saberi, H; Soleimannejad, M | 1 |
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA | 1 |
1 trial(s) available for atorvastatin and Brain Neoplasms
Article | Year |
---|---|
Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Temozolomide; Young Adult | 2021 |
6 other study(ies) available for atorvastatin and Brain Neoplasms
Article | Year |
---|---|
Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma.
Topics: Animals; Astrocytes; Atorvastatin; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Knock-In Techniques; Glioma; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isocitrate Dehydrogenase; Mice; Mice, Transgenic; Mutation; Myelin Sheath; Primary Cell Culture | 2020 |
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.
Topics: Animals; Atorvastatin; Brain Neoplasms; Cell Proliferation; Cell Survival; Dacarbazine; Disease Models, Animal; Glioblastoma; Humans; Mice; Neoplasms, Experimental; ras Proteins; Signal Transduction; Temozolomide; Tumor Cells, Cultured | 2017 |
Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.
Topics: Atorvastatin; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioblastoma; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Microglia; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pyrroles | 2013 |
Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Atorvastatin; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Glioma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Temozolomide | 2018 |
Anti-inflammatory Effects of Atorvastatin in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.
Topics: Anti-Inflammatory Agents; Atorvastatin; Brain Neoplasms; Cell Culture Techniques; Cell Proliferation; Dose-Response Relationship, Drug; Glioblastoma; Humans; Inflammation Mediators; Spheroids, Cellular; Treatment Outcome | 2018 |
Tuberculosis in a patient on temozolomide: a case report.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2009 |